Valeant Pharmaceuticals pulls and re-files antitrust paperwork for Obagi Medical buyout
Valeant Pharmaceuticals International has pulled and re-filed its premerger notification paperwork for the acquisition of specialty pharmaceutical company Obagi Medical Products. The new deadline for the antitrust waiting period is April 19,...To view the full article, register now.
Already a subscriber? Click here to view full article